Medical News

RSS

LifeBond granted Chinese patent for novel absorbable surgical adhesive technology

LifeBond Ltd., a leading developer of absorbable biosurgical products for tissue repair, announced today that the State Intellectual Property Office of the People's Republic of China has granted the company its first Chinese patent.

10 Apr 2014

NIH study could offer clues for developing new antiviral treatments

A National Institutes of Health study reports that a rare genetic disease, while depleting patients of infection-fighting antibodies, may actually protect them from certain severe or recurrent viral infections.

10 Apr 2014

Small financial incentives can improve people’s completion of HBV vaccination, study finds

Small financial incentives, totalling as little as £30, can dramatically increase the likelihood of people who inject drugs completing a course of hepatitis B virus (HBV) vaccination, according to new research published in The Lancet.

10 Apr 2014

Adocia announces positive results from BioChaperone Lispro phase IIa clinical trial

Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly’s Humalog commercial insulin. Adocia’s formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.

10 Apr 2014

CMS releases trove of Medicare physician billing data

The Centers for Medicare & Medicaid Services is making this information available for the first time in 35 years. Meanwhile, in their first run at the data, news outlets report that a small number of doctors account for a large share of Medicare costs.

10 Apr 2014

Study shows dabrafenib has no added benefit in comparison with dacarbazine

Dabrafenib (trade name: Tafinlar) has been approved since August 2013 for the treatment of advanced melanoma. In January 2014, in an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) had determined that dabrafenib has no added benefit in comparison with dacarbazine.

10 Apr 2014

Study identifies two cell surface receptors that may be responsible for spread of lung cancer

Two cell surface receptors might be responsible for the most common form of lung cancer spreading to other parts of the body, according to a study led by the Translational Genomics Research Institute.

10 Apr 2014

Natural compound from green tomatoes protects against muscle atrophy

Using a screening method that previously identified a compound in apple peel as a muscle-boosting agent, a team of University of Iowa scientists has now discovered that tomatidine, a compound from green tomatoes, is even more potent for building muscle and protecting against muscle atrophy.

10 Apr 2014

Moffitt Cancer Center initiates phase I clinical trial of cancer vaccine ID-G305

Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305, made by Immune Design. Immunotherapy is a treatment option that uses a person's own immune system to fight cancer. It has several advantages over standard cancer therapies, including fewer side effects and an overall better tolerability. It tends to be most effective in patients who have smaller, localized tumors that have not spread to distant sites.

10 Apr 2014

Scientists working on new blood test to diagnose stroke faster

When someone suffers from a stroke, a silent countdown begins. A fast diagnosis and treatment can mean the difference between life and death. So scientists are working on a new blood test that one day could rapidly confirm whether someone is having a stroke and what kind. Their report appears in the ACS journal Analytical Chemistry.

10 Apr 2014

Siemens, NKF form new alliance to improve screening for kidney disease in high-risk individuals

Siemens Healthcare and the National Kidney Foundation (NKF) announced today a new strategic alliance focusing on education, awareness and screening for kidney disease in high-risk individuals. This important collaboration will leverage the latest testing recommendations from the NKF to improve detection among the 73 million Americans at risk for kidney disease.

10 Apr 2014

New drug for treating Rett syndrome is on the horizon

A powerful new drug which could relieve the symptoms of devastating childhood disease Rett syndrome is on the horizon thanks to a funding injection of -180,000.

10 Apr 2014

Older people with memory and thinking problems may have lower risk of dying from cancer

Older people who are starting to have memory and thinking problems, but do not yet have dementia may have a lower risk of dying from cancer than people who have no memory and thinking problems, according to a study published in the April 9, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

10 Apr 2014

Novel discovery could lead to new therapy to combat obesity, diabetes

By manipulating a biochemical process that underlies cells' energy-burning abilities, investigators at Beth Israel Deaconess Medical Center have made a novel discovery that could lead to a new therapy to combat obesity and diabetes.

10 Apr 2014

Portrait of newly insured takes shape

Early enrollees in the health law's marketplaces were more likely to use expensive specialty drugs and less likely to use contraceptives, according to an analysis of two months of drug claims data by Express Scripts. A Rand analysis, meanwhile, argues that most of the newly insured signed up with an employer rather than buying it through the marketplaces.

10 Apr 2014

University of Montreal scientists discover molecular details of kissing disease virus attacks

University of Montreal researchers have discovered how a component of the Epstein Barr (EBV) virus takes over our cells gene regulating machinery, allowing the virus to replicate itself.

10 Apr 2014

Treating advanced cervical cancer: an interview with Dr. Krishnansu Tewari

Cervical cancer affects approximately 500,000 women every year globally of which 250,000 die annually, making it the 2nd leading cause of cancer-related death in women.

9 Apr 2014

Risk factors for complete, attempted suicide in schizophrenia 'confirmed'

Among individuals with schizophrenia, those earliest in their illness course and those with a history of suicide attempts have the highest suicide-related mortality rates, reveals analysis of the international Ziprasidone Observational Study of Cardiac Outcomes.

9 Apr 2014

High relapse rates in bipolar disorder confirmed

Results from a naturalistic study show that there is a high risk of relapse among bipolar disorder patients, particularly if their medication is changed or stopped.

9 Apr 2014

Think Possible video from BioTek wins Silver Telly Award

BioTek's Think Possible video, created by Hen House Media, was recently awarded a Silver Telly Award in the "Non-Broadcast, Motivational" category as part of the 35th Annual Telly Awards. Standing out from over 12,000 entries, the Silver Telly is the highest honor bestowed upon film and video productions, and awarded to less than 10 percent of entries.

9 Apr 2014

Medical News

LifeBond granted Chinese patent for novel absorbable surgical adhesive technology

NIH study could offer clues for developing new antiviral treatments

Small financial incentives can improve people’s completion of HBV vaccination, study finds

Adocia announces positive results from BioChaperone Lispro phase IIa clinical trial

CMS releases trove of Medicare physician billing data

Study shows dabrafenib has no added benefit in comparison with dacarbazine

Study identifies two cell surface receptors that may be responsible for spread of lung cancer

Natural compound from green tomatoes protects against muscle atrophy

Moffitt Cancer Center initiates phase I clinical trial of cancer vaccine ID-G305

Scientists working on new blood test to diagnose stroke faster

Siemens, NKF form new alliance to improve screening for kidney disease in high-risk individuals

New drug for treating Rett syndrome is on the horizon

Older people with memory and thinking problems may have lower risk of dying from cancer

Novel discovery could lead to new therapy to combat obesity, diabetes

Portrait of newly insured takes shape

University of Montreal scientists discover molecular details of kissing disease virus attacks

Treating advanced cervical cancer: an interview with Dr. Krishnansu Tewari

Risk factors for complete, attempted suicide in schizophrenia 'confirmed'

High relapse rates in bipolar disorder confirmed

Think Possible video from BioTek wins Silver Telly Award

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News